Jeffrey V. Poulton
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 11464,159 held (−0%) | $319.03 | $36K | -27.1% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 10964,050 held (−0%) | $320.01 | $35K | -27.3% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 23063,820 held (−0%) | $320.81 | $74K | -27.5% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 30963,511 held (−0%) | $321.82 | $99K | -27.7% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 37463,137 held (−1%) | $323.01 | $121K | -28.0% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 81862,319 held (−1%) | $323.84 | $265K | -28.1% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 29162,028 held (−0%) | $324.88 | $95K | -28.4% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 22361,805 held (−0%) | $325.67 | $73K | -28.6% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 6566,414 held (−0%) | $323.62 | $21K | -28.1% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 12466,290 held (−0%) | $324.65 | $40K | -28.3% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 35665,934 held (−1%) | $325.63 | $116K | -28.5% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 54165,393 held (−1%) | $326.81 | $177K | -28.8% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 45464,939 held (−1%) | $327.67 | $149K | -29.0% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 13864,801 held (−0%) | $328.71 | $45K | -29.2% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 23464,567 held (−0%) | $329.71 | $77K | -29.4% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 11264,455 held (−0%) | $330.85 | $37K | -29.7% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 12964,326 held (−0%) | $331.93 | $43K | -29.9% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 5364,273 held (−0%) | $332.64 | $18K | -30.1% |
| Feb 17SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 2,24259,802 held (−4%) | $310.08 | $695K | -25.0% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 7260,173 held (−0%) | $353.95 | $25K | -34.3% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 7860,095 held (−0%) | $355.16 | $28K | -34.5% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 7660,019 held (−0%) | $356.09 | $27K | -34.7% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 17659,843 held (−0%) | $357.17 | $63K | -34.9% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 22659,617 held (−0%) | $358.18 | $81K | -35.0% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 15659,461 held (−0%) | $359.14 | $56K | -35.2% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 28459,177 held (−0%) | $360.22 | $102K | -35.4% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 18158,996 held (−0%) | $361.45 | $65K | -35.6% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 13558,861 held (−0%) | $362.38 | $49K | -35.8% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 8758,774 held (−0%) | $363.55 | $32K | -36.0% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 36558,409 held (−1%) | $364.83 | $133K | -36.2% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 40558,004 held (−1%) | $365.56 | $148K | -36.3% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 9257,912 held (−0%) | $366.41 | $34K | -36.5% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 7657,836 held (−0%) | $367.40 | $28K | -36.7% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 17057,666 held (−0%) | $368.62 | $63K | -36.9% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 7357,593 held (−0%) | $369.48 | $27K | -37.0% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 3657,557 held (−0%) | $370.87 | $13K | -37.3% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 657,551 held (−0%) | $372.46 | $2K | -37.5% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 2557,526 held (−0%) | $374.44 | $9K | -37.9% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 3457,492 held (−0%) | $375.65 | $13K | -38.1% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 2757,465 held (−0%) | $377.82 | $10K | -38.4% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 15057,723 held (−0%) | $446.53 | $67K | -47.9% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 7357,650 held (−0%) | $447.92 | $33K | -48.1% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 23457,416 held (−0%) | $448.77 | $105K | -48.2% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 32457,092 held (−1%) | $449.79 | $146K | -48.3% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 70456,388 held (−1%) | $450.81 | $317K | -48.4% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 43255,956 held (−1%) | $451.86 | $195K | -48.5% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 86955,087 held (−2%) | $452.69 | $393K | -48.6% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 42854,659 held (−1%) | $453.77 | $194K | -48.7% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 31754,342 held (−1%) | $454.84 | $144K | -48.8% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 9554,247 held (−0%) | $455.82 | $43K | -49.0% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 19154,056 held (−0%) | $457.43 | $87K | -49.1% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 454,052 held (−0%) | $457.64 | $2K | -49.2% |